Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects
|ClinicalTrials.gov Identifier: NCT01778257|
Recruitment Status : Completed
First Posted : January 29, 2013
Last Update Posted : January 29, 2013
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Dietary Supplement: Mate extract Dietary Supplement: Placebo||Phase 2|
The primary aim of the study was to investigate the effect of Mate extracts in Korean subjects on body fat and abdominal fat, double blind, placebo-controlled clinical trial.
Thirty obesity subjects with BMI ≥ 25 kg/㎡ and waist-hip ratio (WHR)≥ 0.90 for men and ≥ 0.85 for women were for 12 weeks.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Mate Extract Supplementation Reduces Body and Abdominal Fat in Obese Korean Subjects|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||February 2012|
|Actual Study Completion Date :||March 2012|
Experimental: Mate extracts group
Mate extract(3150 mg/day)for 12 weeks
Dietary Supplement: Mate extract
Mate is a South American herb that is traditionally prepared as a tea and used, among others, for weight reduction.
Other Name: Extracts of Ilex paraguariensis A. St.-Hil.
Placebo Comparator: Placebo group
Placebo (3150 mg/day) for 12 weeks
Dietary Supplement: Placebo
Amount and calorie of placebo are same with Mate extracts.
- Changes in body and abdominal fat [ Time Frame: body fat: baseline, 6 weeks and 12 weeks, abdominal fat of CT: baseline and 12 weeks ]
- Changes in anthropometric parameters(weight, BMI, waist and hip circumference) [ Time Frame: baseline, 6 weeks and 12 weeks ]
- Changes in blood lipid profile(total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, free fatty acid) [ Time Frame: baseline, 6 weeks and 12 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01778257
|Principal Investigator:||Min-Gul Kim, MD||Chonbuk National University Hospital|